½ÃÀ庸°í¼­
»óǰÄÚµå
1675434

ȯÀÚ Ã¼¿Â °ü¸® ½ÃÀå : Á¦Ç°º°, ÀûÀÀº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°(2025-2033³â)

Patient Temperature Management Market Report by Product, Application, End Use, and Region 2025-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 149 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ È¯ÀÚ Ã¼¿Â °ü¸® ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 37¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀåÀÌ 2033³â±îÁö 64¾ï ´Þ·¯¿¡ ´ÞÇϸç, 2025-2033³âÀÇ ¼ºÀå·ü(CAGR)Àº 6.05%¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ¸¹Àº ÁúȯÀÇ ¹ßÁõÀ» ŽÁöÇϱâ À§ÇØ Ã¼¿ÂÀ» À¯ÁöÇÒ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ´Â °Í, ü¿Â ÀúÇÏ·Î ¿¬°áµÉ °¡´É¼ºÀÌ ÀÖ´Â ¿Ü°ú¼ö¼úÀÇ °Ç¼ö°¡ Áõ°¡Çϰí ÀÖ´Â °Í, ü¿Â Á¶Àý ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ´Â °ÍÀÌ ½ÃÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÇ ÀϺÎÀÔ´Ï´Ù.

ü¿Â °ü¸®¶ó°íµµ Çϴ ȯÀÚ Ã¼¿Â °ü¸®´Â ÀÇ·á ÀýÂ÷, ¼ö¼ú ¶Ç´Â ÁßȯÀÚ Ä¡·á¿¡¼­ ȯÀÚÀÇ ÃÖÀû ü¿ÂÀ» À¯ÁöÇÏ´Â °ÍÀ» Æ÷ÇÔÇÏ´Â ÀÇ·áÀÇ Áß¿äÇÑ Ãø¸éÀÔ´Ï´Ù. ȯÀÚÀÇ Ã¼¿ÂÀ» ¸ð´ÏÅ͸µ, Á¶Àý ¹× Á¦¾îÇϱâ À§ÇØ ¼³°èµÈ ¿Â¿­ ´ã¿ä, ³Ã°¢ ÆÐµå, ¿Âµµ ¼¾¼­, ÅëÇÕ ¿Âµµ °ü¸® ½Ã½ºÅÛ µî ´Ù¾çÇÑ Àåºñ¿Í ±â¼ú¿¡ ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. ȯÀÚÀÇ Ã¼¿ÂÀÌ ¾ÈÀüÇÏ°í ¹Ù¶÷Á÷ÇÑ ¹üÀ§ ³»¿¡¼­ À¯ÁöµÇµµ·Ï ÇÔÀ¸·Î½á °á°ú¸¦ °³¼±Çϰí ÇÕº´ÁõÀÇ À§ÇèÀ» ÁÙÀÔ´Ï´Ù. ÀûÀýÇÑ Ã¼¿ÂÀ» À¯ÁöÇÔÀ¸·Î½á ¼ö¼ú ºÎÀ§ °¨¿°°ú ÃâÇ÷ÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­Çϰí, ȯÀÚÀÇ Æí¾ÈÇÔ°ú ȸº¹À» °³¼±ÇÏ¿© ±àÁ¤ÀûÀÎ ÀÓ»ó °á°ú¿¡ ±â¿©ÇÕ´Ï´Ù. ÇÕº´Áõ °¨¼Ò¿Í Ãß°¡ Ä¡·áÀÇ Çʿ伺 °¨¼Ò·Î ÀÔ¿ø ±â°£ ´ÜÃà ¹× ÀÇ·áºñ Àý°¨¿¡ ±â¿©ÇϹǷΠÀü ¼¼°è¿¡¼­ ȯÀÚ Ã¼¿Â °ü¸®¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ȯÀÚ Ã¼¿Â °ü¸® ½ÃÀå µ¿Çâ :

ÇöÀç ¸¹Àº Áúº´ÀÇ ¹ßº´ °¨Áö, ÁøÇà Æò°¡, Áø´Ü, Ä¡·á ¹æÄ§ °áÁ¤ µîÀ» À§ÇØ Ã¼¿ÂÀ» À¯ÁöÇØ¾ß ÇÒ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀÌ ½ÃÀå ¼ºÀåÀ» À̲ô´Â Áß¿äÇÑ ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ ÁßÁõ ȯÀÚ³ª ¼ö¼ú ȯÀÚÀÇ Ã¼¿ÂÀ» ½±°Ô °ü¸®Çϱâ À§ÇØ °£È£»çÀÇ È¯ÀÚ Ã¼¿Â °ü¸® ¼Ö·ç¼Ç »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. À̴ ȯÀÚ Ã¼¿Â °ü¸®ÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ´ëÁßÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àü ¼¼°è¿¡¼­ ¸¸¼ºÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ȯÀÚ Ã¼¿Â °ü¸® ÀåºñÀÇ Á¦Á¶ °øÁ¤¿¡¼­ ±â¼ú Çõ½ÅÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ ÁÖ¿ä ±â¾÷Àº Â÷¼¼´ë °íÀ¯·® ´ë·ù½Ä ¿Â¿­±â¸¦ µµÀÔÇÏ¿© ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô ½±°í ¾ÈÀüÇÑ ¿Â¿­ Ä¡·á ¼Ö·ç¼ÇÀ» Á¦°øÇÏ¿© ȯÀÚ°¡ ¼ö¼úÀÇ ¸ðµç ´Ü°è¿¡¼­ Á¤»óÀûÀΠü¿ÂÀ» À¯ÁöÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ¼ö¼ú Àü ȯÀÚ¿¡°Ô Åõ¿©µÇ´Â ±¹¼Ò¸¶ÃëÁ¦³ª Àü½Å¸¶ÃëÁ¦·Î ÀÎÇØ ü¿ÂÀÌ ¶³¾îÁú ¼ö ÀÖ´Â ¼ö¼ú °Ç¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå Àü¸ÁÀº ¾çÈ£ÇÕ´Ï´Ù. ¶ÇÇÑ Ç¥¸é ÆÐµå, ´ã¿ä, Çìµåĸ°ú °°Àº ü¿Â Á¶Àý Àåºñ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÀÇ·á »ê¾÷ÀÇ ¹ø¿µ°ú ÇÔ²² ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

  • ¼¼°è ȯÀÚ Ã¼¿Â °ü¸® ½ÃÀåÀº Áö±Ý±îÁö ¾î¶»°Ô ÃßÀÌÇØ ¿Ô´Â°¡?
  • ¼¼°è ȯÀÚ Ã¼¿Â °ü¸® ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ ¹× ±âȸ´Â?
  • °¢ ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ ¹× ±âȸ°¡ ¼¼°è ȯÀÚ Ã¼¿Â °ü¸® ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀº?
  • ÁÖ¿ä Áö¿ª ½ÃÀåÀº?
  • °¡Àå ¸Å·ÂÀûÀΠȯÀÚ Ã¼¿Â °ü¸® ½ÃÀåÀº ¾î´À ±¹°¡Àΰ¡?
  • Á¦Ç°º° ½ÃÀå ºÐ¼®Àº?
  • ȯÀÚ Ã¼¿Â °ü¸® ½ÃÀå¿¡¼­ °¡Àå ¸Å·ÂÀûÀÎ Á¦Ç°Àº?
  • ÀûÀÀÁõº° ½ÃÀå ºÐ¼®Àº?
  • ȯÀÚ Ã¼¿Â °ü¸® ½ÃÀå¿¡¼­ °¡Àå ¸Å·ÂÀûÀÎ ÀûÀÀÁõÀº?
  • ÃÖÁ¾ ¿ëµµº° ½ÃÀå ºÐ¼®Àº?
  • ȯÀÚ Ã¼¿Â °ü¸® ½ÃÀå¿¡¼­ °¡Àå ¸Å·ÂÀûÀÎ ÃÖÁ¾ ¿ëµµ´Â?
  • ¼¼°è ȯÀÚ Ã¼¿Â °ü¸® ½ÃÀåÀÇ °æÀï ±¸µµ´Â?
  • ¼¼°è ȯÀÚ Ã¼¿Â °ü¸® ½ÃÀå¿¡¼­ ÁÖ¿ä ±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»çÀÇ ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • º¸ÅÒ¾÷ ¾îÇÁ·ÎÄ¡
    • Åé´Ù¿î ¾îÇÁ·ÎÄ¡
  • Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ¼­·Ð

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ È¯ÀÚ Ã¼¿Â °ü¸® ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ³»¿ª : Á¦Ç°º°

  • ȯÀÚ °¡¿Â ½Ã½ºÅÛ
  • ȯÀÚ ³Ã°¢ ½Ã½ºÅÛ

Á¦7Àå ½ÃÀå ³»¿ª : ÀûÀÀº°

  • ¼ö¼ú
  • ½ÉÀ庴
  • ¼Ò¾Æ
  • ½Å°æ
  • Á¤Çü¿Ü°ú
  • ±âŸ

Á¦8Àå ½ÃÀå ³»¿ª : ÃÖÁ¾ ¿ëµµº°

  • ¼ö¼ú½Ç
  • ½Å»ý¾Æ ÁýÁßÄ¡·á½Ç
  • ÀÀ±Þ½Ç
  • ÁýÁßÄ¡·á½Ç
  • ±âŸ

Á¦9Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå ³»¿ª : ±¹°¡º°

Á¦10Àå ÃËÁø¿äÀΡ¤¾ïÁ¦¿äÀΡ¤±âȸ

  • °³¿ä
  • ÃËÁø¿äÀÎ
  • ¾ïÁ¦¿äÀÎ
  • ±âȸ

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ¹ÙÀ̾îÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀïÀÇ Á¤µµ
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ÀÇ °³¿ä
    • 3M Company
    • Atom Medical Corporation
    • Becton Dickinson and Company
    • Belmont Medical Technologies
    • Braincool AB(Dignitana)
    • Ecolab Inc.
    • Medtronic Plc
    • Moeck & Moeck GmbH
    • O&M Halyard Inc.(Owens & Minor Inc.)
    • pfm medical hico gmbh
    • Smiths Medical Inc.(ICU Medical Inc.)
    • Stryker Corporation
    • ZOLL Medical Corporation(Asahi Kasei Corporation)
KSA 25.04.07

The global patient temperature management market size reached USD 3.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.4 Billion by 2033, exhibiting a growth rate (CAGR) of 6.05% during 2025-2033. The growing need to maintain the body temperature to detect the onset of many diseases, rising number of surgical procedures that can lead to decreased body temperature and increasing demand for thermoregulatory devices represent some of the key factors driving the market.

Patient temperature management, also known as thermal management, is a critical aspect of healthcare that involves maintaining optimal body temperature for patients during medical procedures, surgeries, or critical care settings. It relies on a variety of equipment and technologies, such as warming blankets, cooling pads, temperature sensors, and integrated temperature management systems, which are designed to monitor, regulate, and control the body temperature of patients. It ensures that the body temperature of patients remains within a safe and desired range to promote better outcomes and reduce the risk of complications. It helps minimize the risk of surgical site infections and blood loss, improves patient comfort and recovery, and contributes to positive clinical outcomes by maintaining proper body temperature. As it assists in shortening hospital stays and lowering healthcare costs due to reduced complications and the need for additional treatments, the demand for patient temperature management is rising around the world.

Patient Temperature Management Market Trends:

At present, the increasing need to maintain the body temperature for detecting the onset of many diseases, assessing their progression, making diagnoses, and deciding the type of treatment represents one of the key factors supporting the growth of the market. In addition, there is a rise in the utilization of patient temperature management solutions by nursing staff to manage the core body temperature of critically ill and surgical patients easily. This, along with the growing awareness among the masses about the benefits of patient temperature management, is positively influencing the market. Moreover, the increasing number of innovations in the manufacturing process of patient temperature management devices due to the rising prevalence of chronic diseases worldwide is propelling the growth of the market. Besides this, key players are introducing the next-generation high-flow convective warmer that gives healthcare providers a simple and safe thermal care solution to assist patients in maintaining normal body temperature through every stage of surgery. In line with this, the growing number of surgical procedures that can lead to decreased body temperature due to local or general anesthetics given to patients before surgery is offering a favorable market outlook. Additionally, the rising demand for thermoregulatory devices, such as surface pads, blankets, and head caps, along with the thriving medical industry, is bolstering the growth of the market.

Key Market Segmentation:

Product Insights:

  • Patient Warming Systems
  • Patient Cooling Systems

Application Insights:

  • Surgery
  • Cardiology
  • Pediatrics
  • Neurology
  • Orthopedic Surgery
  • Others

End Use Insights:

  • Operating Room
  • Neonatal ICU
  • Emergency Room
  • ICUs
  • Others

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for patient temperature management. Some of the factors driving the North America patient temperature management market included the growing geriatric population, rising healthcare expenditure, increasing number of hospitals and ambulatory care centers, etc.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global patient temperature management market. Detailed profiles of all major companies have been provided. Some of the companies covered include 3M Company, Atom Medical Corporation, Becton Dickinson and Company, Belmont Medical Technologies, Braincool AB (Dignitana), Ecolab Inc., Medtronic Plc, Moeck & Moeck GmbH, O&M Halyard Inc. (Owens & Minor Inc.), pfm medical hico gmbh, Smiths Medical Inc. (ICU Medical Inc.), Stryker Corporation, ZOLL Medical Corporation (Asahi Kasei Corporation), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global patient temperature management market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global patient temperature management market?
  • What is the impact of each driver, restraint, and opportunity on the global patient temperature management market?
  • What are the key regional markets?
  • Which countries represent the most attractive patient temperature management market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the patient temperature management market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the patient temperature management market?
  • What is the breakup of the market based on the end use?
  • Which is the most attractive end use in the patient temperature management market?
  • What is the competitive structure of the global patient temperature management market?
  • Who are the key players/companies in the global patient temperature management market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Patient Temperature Management Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Patient Warming Systems
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Patient Cooling Systems
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Surgery
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cardiology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Pediatrics
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Neurology
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Orthopedic Surgery
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Operating Room
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Neonatal ICU
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Emergency Room
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 ICUs
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3M Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Atom Medical Corporation
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Becton Dickinson and Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Belmont Medical Technologies
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Braincool AB (Dignitana)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Ecolab Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Medtronic Plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Moeck & Moeck GmbH
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 O&M Halyard Inc. (Owens & Minor Inc.)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 pfm medical hico gmbh
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Smiths Medical Inc. (ICU Medical Inc.)
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Stryker Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 ZOLL Medical Corporation (Asahi Kasei Corporation)
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦